載入...
Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system
Osteosarcoma is the most common type primary malignant tumor of bone. Patients with regional osteosarcoma are routinely treated with surgery and chemotherapy. In addition, many patients with metastatic or recurrent osteosarcoma show poor prognosis with current chemotherapy agents. Therefore, it is i...
Na minha lista:
發表在: | J Orthop Res |
---|---|
Main Authors: | , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
2014
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4304907/ https://ncbi.nlm.nih.gov/pubmed/25348612 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jor.22745 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|